AzTrials
AzTrials

Premature BirthNCT03232190

The Use of an Age-linked App for Parents During and After a NICU Stay

A study testing Web Application in people with Premature Birth, run by Ziekenhuis Oost-Limburg at 1 site in Belgium.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The main purpose of the neonatal intensive care unit (NICU) is to optimize the development of the newborn. Preterm children are at greater risk for developmental disorders. On the one hand, this is due to cerebral complications inherent to the prematurity, on the other hand it is related to the very early and… Read more about this study

Who is it for?
Ages Up to 32 weeks
Conditions the study is for
Premature Birth
What is being tested?
Web Application
Could I receive a placebo?
No, everyone receives an active treatment
How many people
180 participants
Where
1 siteBelgium
Study dates
Jan 2014to Dec 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 32 weeks
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Premature birth (< 32 weeks)

Who cannot join

  • The lack of internet access or a personal email account
  • Little or no knowledge of Dutch in both parents
  • Children with a congenital disease

Trial locations and contacts

1 site in 1 country.

Marie-Rose Van Hoestenberghe, MD. contact

+32 89 32 76 33

marie-rose.vanhoestenberghe@zol.be

Belgium1 site, 1 recruiting
  • Ziekenhuis Oost-Limburg, Schiepse Bos 6

    Genk, Limburg, 3600

    Recruiting

Other trials in Belgium

About this study

Official title: The Use of an Age-linked Web Application for Parents During and After a NICU Stay in Improving Child Development and Parent Empowerment

The main purpose of the neonatal intensive care unit (NICU) is to optimize the development of the newborn. Preterm children are at greater risk for developmental disorders. On the one hand, this is due to cerebral complications inherent to the prematurity, on the other hand it is related to the very early and therefore vulnerable stage of brain development at the time of the premature birth. The development of the child is also the result of a constant interaction between the infant and its environment, primarily the primary caregiver (i.e. the parents). A premature birth can cause great stress to parents, and there are several obstacles that can make it difficult to handle their child. Therefore, we have developed a web application that supports parents until their child reaches the age of two. By keeping them informed, we hope to make them more confident in their role as parents, and thus facilitate the parent-child interaction. In order to determine whether this form of support has an additional effect on the development of the premature child, we compare two groups of premature infants and a group of non-premature infants.

Conditions
Premature Birth
Being tested
Web Application
Keywords
prematurity, psychomotor development, parent empowerment, e-health, parental support, post discharge follow-up
Medical subject headings
Premature Birth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Web ApplicationOther

    Parents receive a web application that offers information and support until the age of 2.

Study groups in NCT03232190
Study groupRoleWhat they receive
INTNICExperimentalNICU Intervention Group Web Application Infants < 32 weeks
Receives: Other: Web Application
CNICNo interventionNICU Control Group No Web Application Infants < 32 weeks
CMATNo interventionMaternity Unit Control Group No Web Application Infants > 37 weeks

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Bayley-III-NL

    Bayley Scales of Infant and Toddler Development Mental, social and motor development of the child

    Measured: 5 months, 1 year, 2 year

  2. Change in DT-P

    Distress Thermometer for Parents

    Measured: 2 weeks after birth, 37 weeks PMA, 5 months, 1 year, 2 year, 5 year

  3. Change in EMPO

    Dutch Empowerment Questionnaire Parental empowerment in raising children (intrapersonal, interactional, and behavioral)

    Measured: 2 weeks after birth, 37 weeks PMA, 5 months, 1 year, 2 year, 5 year

  4. WPPSI-III-NL

    Wechsler Preschool and Primary Scale of Intelligence Cognitive Development of the Child

    Measured: 5 year

Secondary outcomes (1)
  1. Change in PNAR

    Parent Newborn Attachment Relationship Questionnaire

    Measured: 2 weeks after birth, 37 weeks PMA, 5 months, 1 year, 2 year, 5 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jul 2017
  2. Study startJan 2014
  3. Primary completionDec 2022 (estimated)
  4. Study completionDec 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
180 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03232190
Sponsor's protocol ID
B331201422729
Status last verified
Jul 2019
First submitted
16 Feb 2017
Last updated
31 Jul 2019
Results posted
No
Data monitoring committee
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Web Application in people with Premature Birth, run by Ziekenhuis Oost-Limburg at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 31 Jul 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Marie-Rose Van Hoestenberghe, MD. (+32 89 32 76 33, marie-rose.vanhoestenberghe@zol.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Bayley-III-NL (time frame: 5 months, 1 year, 2 year). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jul 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in